Business and Innovation

Subspecialties Business and Innovation

01/03/2020 | Eric Bernabei

Combining genetic testing with AI and machine learning offers virtually unlimited opportunities in disease detection, management, and treatment

Business & Profession Professional Development

01/02/2020

Sitting Down With… Tim Clover, CEO of Rayner

Subspecialties Imaging & Diagnostics

12/30/2019 | Sponsored by Zeiss

The ARTEVO® 800 from ZEISS: a paradigm shift in ophthalmic visualization

Subspecialties Business and Innovation

12/23/2019 | Sponsored by EyeMD

EyeMD EMR’s newest release harnesses fog computing architecture to deliver a system without compromise

Subspecialties Health Economics and Policy

12/17/2019 | Michael D. Abramoff, Pearse Keane, Stephen Odaibo, Daniel Ting

Four AI and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next

Subspecialties Retina

12/05/2019 | Jim Taylor

Electrical stimulation of neural responses can significantly improve outcomes for retinitis pigmentosa patients

Subspecialties Health Economics and Policy

12/02/2019 | Aleksandra Jones

When even the world’s wealthiest economies struggle to fund gene therapies, we have a problem that demands disruptive solutions

Subspecialties Retina

10/29/2019 | Rod McNeil

Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency

Business & Profession Business and Innovation

10/04/2019

Ahead of the Ophthalmology Innovation Summit 2019 at AAO, we reach out to a panel of experts to uncover market trends

Subspecialties Refractive

09/06/2019 | Sponsored by Rayner

Rayner turns its focus to big data and patient centricity with a new digital platform: RayPRO.